by aparada | May 13, 2020 | News FJB |
• FairJourney’s combination with Iontas creates a leading global antibody discovery Clinical Research Organisation (‘CRO’) with an international footprint • FairJourney’s unique antibody discovery libraries and service portfolio to be complemented by Iontas’...
by aparada | Apr 16, 2020 | News FJB |
16 April 2020 • Bringing together complementary services and technology to allow faster identification of effective antibodies with a higher chance of success in development FairJourney Biologics (Porto, Portugal) and Iontas (Cambridge, UK) today announce a...
by aparada | Sep 1, 2017 | News FJB |
FairJourney Biologics’ CSO Maria Pajuelo will make a presentation about Triple Vector for Discovery of Antibody Molecules in Full Therapeutic Format, at the 9th annual of PEGS Europe – Protein & Antibody Engineering Summit, on Tuesday, 14th of November 2017, at...
by aparada | Aug 23, 2017 | News FJB |
FairJourney Biologics co-authors a Nature Medicine paper entitled: A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels. Nat Med. 2017 Aug 21. doi: 10.1038/nm.4390....
by aparada | May 10, 2017 | News FJB |
New technology to discover antibody molecules in full therapeutic format FairJourney-Biologics-announces-an-innovative-technology-to-discover-antibody-molecules-in-full-therapeutic-format.pdf...
by aparada | Apr 3, 2017 | News FJB |
A new anti-mesothelin antibody targets selectively the membrane-associated form. MAbs. 2017 Apr;9(3):567-577. doi: 10.1080/19420862.2017.1288770. (https://www.ncbi.nlm.nih.gov/pubmed/28353419)
